quinazolines has been researched along with phloretin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, G; Szabo, M | 1 |
Dokuni, R; Kiriu, T; Kobayashi, K; Kunimasa, K; Nagano, T; Nishimura, Y; Satouchi, M; Shimono, Y; Tachihara, M; Tamura, D; Tokunaga, S; Yamamoto, M | 1 |
2 other study(ies) available for quinazolines and phloretin
Article | Year |
---|---|
Adenosine 3',5'-cyclic phosphate phosphodiesterase from bovine thyroid: isolation and properties of a partially purified, soluble fraction.
Topics: Animals; Butyrates; Cations, Divalent; Cattle; Chromatography, Ion Exchange; Cyclic AMP; Cyclopentanes; Dicarboxylic Acids; Enzyme Activation; Fatty Acids; Kidney; Kinetics; Long-Acting Thyroid Stimulator; Magnesium; Methyl Ethers; Myocardium; Phloretin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prostaglandins; Protein Binding; Quinazolines; Sulfonylurea Compounds; Thyroid Gland; Thyrotropin; Tritium; Xanthines | 1972 |
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cellular Senescence; Drug Resistance, Neoplasm; ErbB Receptors; Flow Cytometry; Gefitinib; Glucose; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplastic Stem Cells; Phloretin; Polymerase Chain Reaction; Protein Kinase Inhibitors; Quinazolines; Withanolides; Xenograft Model Antitumor Assays | 2017 |